Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Turner

Showing results (91-100 of 138) with videos related to

Pageof 14
Sort By:
Annals of the Rheumatic Diseases|February 23, 2019
Reducing arthritis fatigue impact: two-year randomised controlled trial of cognitive behavioural approaches by rheumatology teams (RAFT)Sarah Hewlett, Celia Almeida, Nicholas Ambler, et al.
Breast Cancer Research and Treatment|August 23, 2024
SGLT2 inhibition improves PI3Kα inhibitor-induced hyperglycemia: findings from preclinical animal models and from patients in the BYLieve and SOLAR-1 trialsManuel Ruiz Borrego, Yen-Shen Lu, Felipe Reyes-Cosmelli, et al.
NIHR Open Research|October 26, 2023
The Randomised Evaluation of early topical Lidocaine patches In Elderly patients admitted to hospital with rib Fractures (RELIEF): feasibility trial protocolAmanda Lewis, Madeleine Clout, Jonathan Benger, et al.
Cancer Research|February 25, 2010
FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancerNicholas Turner, Alex Pearson, Rachel Sharpe, et al.
Infection Control and Hospital Epidemiology|January 11, 2021
Risk factors for mortality and progression to severe COVID-19 disease in the Southeast region in the United States: A report from the SEUS Study GroupAthena L V Hobbs, Nicholas Turner, Imad Omer, et al.
Future Oncology (London, England)|April 18, 2023
Design of SERENA-6, a phase III switching trial of camizestrant in <i>ESR1</i>-mutant breast cancer during first-line treatmentNicholas Turner, Cynthia Huang-Bartlett, Kevin Kalinsky, et al.
Breast Cancer Research and Treatment|September 20, 2019
Pathological complete response to neoadjuvant systemic therapy in 789 early and locally advanced breast cancer patients: The Royal Marsden experienceNicolò Matteo Luca Battisti, Victoria True, Narda Chaabouni, et al.
Plos One|July 23, 2024
A pragmatic cluster randomised controlled trial of air filtration to prevent symptomatic winter respiratory infections (including COVID-19) in care homes (AFRI-c) in England: Trial protocolRachel C M Brierley, Jodi Taylor, Nicholas Turner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2013
Targeting FGFR with dovitinib (TKI258): preclinical and clinical data in breast cancerFabrice André, Thomas Bachelot, Mario Campone, et al.
Emergency Medicine Journal : EMJ|May 17, 2024
The RELIEF feasibility trial: topical lidocaine patches in older adults with rib fracturesMadeleine Clout, Nicholas Turner, Clare Clement, et al.
Pageof 14

Showing results (91-100 of 138) with videos related to

Sort By:
Pageof 14
Annals of the Rheumatic Diseases|February 23, 2019
Reducing arthritis fatigue impact: two-year randomised controlled trial of cognitive behavioural approaches by rheumatology teams (RAFT)Sarah Hewlett, Celia Almeida, Nicholas Ambler, et al.
Breast Cancer Research and Treatment|August 23, 2024
SGLT2 inhibition improves PI3Kα inhibitor-induced hyperglycemia: findings from preclinical animal models and from patients in the BYLieve and SOLAR-1 trialsManuel Ruiz Borrego, Yen-Shen Lu, Felipe Reyes-Cosmelli, et al.
NIHR Open Research|October 26, 2023
The Randomised Evaluation of early topical Lidocaine patches In Elderly patients admitted to hospital with rib Fractures (RELIEF): feasibility trial protocolAmanda Lewis, Madeleine Clout, Jonathan Benger, et al.
Cancer Research|February 25, 2010
FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancerNicholas Turner, Alex Pearson, Rachel Sharpe, et al.
Infection Control and Hospital Epidemiology|January 11, 2021
Risk factors for mortality and progression to severe COVID-19 disease in the Southeast region in the United States: A report from the SEUS Study GroupAthena L V Hobbs, Nicholas Turner, Imad Omer, et al.
Future Oncology (London, England)|April 18, 2023
Design of SERENA-6, a phase III switching trial of camizestrant in <i>ESR1</i>-mutant breast cancer during first-line treatmentNicholas Turner, Cynthia Huang-Bartlett, Kevin Kalinsky, et al.
Breast Cancer Research and Treatment|September 20, 2019
Pathological complete response to neoadjuvant systemic therapy in 789 early and locally advanced breast cancer patients: The Royal Marsden experienceNicolò Matteo Luca Battisti, Victoria True, Narda Chaabouni, et al.
Plos One|July 23, 2024
A pragmatic cluster randomised controlled trial of air filtration to prevent symptomatic winter respiratory infections (including COVID-19) in care homes (AFRI-c) in England: Trial protocolRachel C M Brierley, Jodi Taylor, Nicholas Turner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2013
Targeting FGFR with dovitinib (TKI258): preclinical and clinical data in breast cancerFabrice André, Thomas Bachelot, Mario Campone, et al.
Emergency Medicine Journal : EMJ|May 17, 2024
The RELIEF feasibility trial: topical lidocaine patches in older adults with rib fracturesMadeleine Clout, Nicholas Turner, Clare Clement, et al.
Pageof 14